TenSixty BioSciences

Cambridge, United States

TenSixty BioSciences' goal is to identify novel small molecule therapeutics made possible by combining high throughput experiments.

May 2023

Non-equity Assistance

Biotechnology Life Science

Top Investors

General Catalyst Wing Venture Capital Intel Ignite

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TenSixty BioSciences

Who are TenSixty BioSciences's investors?

TenSixty BioSciences's investors include General Catalyst, Wing Venture Capital, Intel Ignite.

Where is TenSixty BioSciences headquartered?

TenSixty BioSciences is headquartered in Cambridge, United States.

What does TenSixty BioSciences do?

TenSixty BioSciences' goal is to identify novel small molecule therapeutics made possible by combining high throughput experiments.

What stage is TenSixty BioSciences at?

TenSixty BioSciences is at the Non-equity Assistance stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 9, 2023.

MLA

"TenSixty BioSciences — Funding & Investors." VCBacked, May 9, 2023, https://www.vcbacked.co/company/tensixty-biosciences. Accessed July 3, 2026.

APA

VCBacked. (2023). TenSixty BioSciences — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/tensixty-biosciences

Wikipedia (cite web)

{{cite web |title=TenSixty BioSciences — Funding & Investors |url=https://www.vcbacked.co/company/tensixty-biosciences |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 9, 2023.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K